Von Willebrand Disease
📧 Sign up to get email alerts when something new happens for Von Willebrand Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-11-11Clinical Trial Update: BT200 in Hereditary Bleeding Disorders [Phase 2]
Phase 2 trial update for BT200 in hereditary bleeding disorders has completed, investigating von Willebrand disease and Hemophilia A.
-
CLINICAL_TRIALS trial_result · 2021-08-06Clinical Trial Update: rVWF IN PROPHYLAXIS [Phase 3]
Phase 3 clinical trial update for recombinant von Willebrand factor (rVWF) used for prophylaxis in von Willebrand disease; trial completed w…
-
CLINICAL_TRIALS trial_result · 2020-02-27Clinical Trial Update: Gingival Bleeding and Von Willebrand Disease Typ 2 and 3
Completed clinical trial update related to gingival bleeding in Von Willebrand disease types 2 and 3; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease
A completed clinical trial updating safety and efficacy surveillance of Wilate in patients with Von Willebrand Disease, with results posted …
-
FDA approval · 2019-10-24FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Apotex Corp.)
FDA approves Apotex Corp.'s supplemental application for Desmopressin Acetate, enabling the generic version to be marketed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2019-07-25FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Meitheal Pharmaceuticals Inc.)
FDA approved a supplemental application for Desmopressin acetate by Meitheal Pharmaceuticals, resulting in a label update associated with th…
-
FDA label_change · 2019-07-25FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for Desmopressin Acetate from Sagent Pharmaceuticals, resulting in changes to the product labeling.
-
FDA approval · 2019-01-28FDA Approved: DESMOPRESSIN ACETATE — Original Application (KVK-TECH, INC.)
The FDA approved Desmopressin Acetate from KVK-Tech under an Original Application, providing a new generic option for this drug product.
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: Study of Voncento® in Subjects With Von Willebrand Disease [Phase 4]
This entry notes the completion of a Phase 4 clinical trial evaluating Voncento in subjects with Von Willebrand disease.
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: A Study to Compare the Pharmacokinetics and Safety of Optivate® and Haemate P® in Patients With Von Willebrand Disease. [Phase 2]
Phase 2 trial comparing pharmacokinetics and safety of Optivate and Haemate P in patients with von Willebrand disease has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: A Study to Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Haemophilia A. [Phase 3]
Phase 3 trial comparing pharmacokinetics and safety of current Factor VIII concentrate versus Optivate in haemophilia A (completed).
-
CLINICAL_TRIALS withdrawal · 2017-11-28Clinical Trial Update: The Effect of the Nutraceutical "Hemofix" on the Coagulation System [NA]
This clinical trial update reports the withdrawal of a study evaluating the nutraceutical Hemofix on coagulation in von Willebrand disease a…
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: The Von Willebrand Disease (VWD) International Prophylaxis Study
A clinical trial update indicating that the Von Willebrand disease international prophylaxis study has completed.
-
CLINICAL_TRIALS trial_result · 2017-10-03Clinical Trial Update: Study of Biostate® in Children With Von Willebrand Disease [Phase 3]
A Phase 3 trial update for Biostate® in children with von Willebrand disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-10-03Clinical Trial Update: Extension Study of Biostate in Subjects With Von Willebrand Disease [Phase 3]
Extension study update for Biostate in Von Willebrand Disease completing Phase 3.
-
CLINICAL_TRIALS trial_result · 2017-10-03Clinical Trial Update: Study of a pd VWF/FVIII Concentrate, Biostate®, in Subjects With Von Willebrand Disease [Phase 2, Phase 3]
Phase 2/3 trial update for Biostate, a pd VWF/FVIII concentrate, in patients with Von Willebrand Disease.
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery [Phase 3]
A Phase 3 trial evaluating recombinant von Willebrand factor in patients with severe von Willebrand disease undergoing surgery has completed…
-
FDA approval · 2017-08-22FDA Approved: DESMOPRESSIN ACETATE — Original Application (Sagent Pharmaceuticals)
FDA approved the Original Application for Desmopressin Acetate (DESMOPRESSIN ACETATE) by Sagent Pharmaceuticals, providing a generic version…
-
FDA approval · 2017-08-22FDA Approved: DESMOPRESSIN ACETATE — Original Application (Sagent Pharmaceuticals)
FDA approved an original application for Desmopressin Acetate from Sagent Pharmaceuticals, establishing a generic version of the product.
-
FDA approval · 2017-05-26FDA Approved: DESMOPRESSIN ACETATE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved an Original Application for Desmopressin Acetate as a generic product manufactured by Heritage Pharmaceuticals Inc. d/b/a Avet …
-
CLINICAL_TRIALS withdrawal · 2017-05-25Clinical Trial Update: Collection of Blood in Normal Subjects and Subjects With Von Willebrand Disease (VWD)
The study on blood collection in normal subjects and in patients with Von Willebrand Disease has been withdrawn.
-
CLINICAL_TRIALS research · 2016-08-31Clinical Trial Update: Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease
This clinical trial update reports ongoing research on global hemostatic methods for Hemophilia A, Hemophilia B, and von Willebrand disease …
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Phase II Study of IL-11 (Neumega) in Von Willebrand Disease [Phase 2]
Phase II study of IL-11 (Neumega) in Von Willebrand Disease has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-21Clinical Trial Update: Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD) [Phase 3]
Phase 3 trial evaluating PK, safety, and efficacy of recombinant von Willebrand factor for treating bleeding episodes in von Willebrand dise…
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: Efficacy and Safety of IL-11 in DDAVP Unresponsive [Phase 2]
Phase 2 trial evaluating the efficacy and safety of interleukin-11 in DDAVP-unresponsive bleeding in Hemophilia A and Von Willebrand disease…